Contact Us
About Us
Subscribe
My Account
Contact Us
About Us
Subscribe
My Account

Insider Transactions by Campanelli Paul

SymbolRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
ENDPDirectorApr 06, 2021 Option Exercise$7.37188,3841,388,3901,607,550Apr 06, 2021, 04:46 PM
ENDPDirectorApr 02, 2021 Option Exercise$7.37146,4001,078,9681,427,634Apr 06, 2021, 04:46 PM
ENDPDirectorMar 29, 2021 Option Exercise$7.3172,926533,3011,274,034Mar 31, 2021, 04:07 PM
ENDPDirectorAug 10, 2020 Option Exercise$3.40116,789397,0831,197,521Aug 12, 2020, 04:13 PM
ENDPDirectorApr 02, 2020 Option Exercise$3.16146,400462,6241,074,985Apr 06, 2020, 04:04 PM
ENDPDirectorMar 29, 2020 Option Exercise$3.5272,926256,700921,385Mar 31, 2020, 04:15 PM
ENDPPresident, CEOFeb 25, 2020 Option Exercise$6.1992,976575,521844,871Feb 25, 2020, 04:42 PM
ENDPPresident, CEOFeb 23, 2020 Option Exercise$6.199986,178729,417Feb 25, 2020, 04:42 PM
ENDPPresident, CEOFeb 21, 2020 Option Exercise$6.1924,184149,699727,460Feb 25, 2020, 04:42 PM
ENDPPresident, CEOSep 28, 2019 Option Exercise$3.121,8745,847675,829Oct 01, 2019, 04:05 PM
ENDPPresident, CEOAug 10, 2019 Option Exercise$2.49116,790290,807673,862Aug 13, 2019, 05:50 PM
ENDPPresident, CEOApr 02, 2019 Option Exercise$8.10146,4001,185,840551,326Apr 04, 2019, 04:31 PM
ENDPPresident, CEOFeb 23, 2019 Option Exercise$10.5199810,489397,726Feb 26, 2019, 05:32 PM
ENDPPresident, CEOFeb 21, 2019 Option Exercise$10.3824,184251,030395,769Feb 25, 2019, 04:41 PM
ENDPPresident, CEOSep 28, 2018 Option Exercise$16.711,80130,095344,138Oct 02, 2018, 04:15 PM
ENDPPresident, CEOAug 10, 2018 Option Exercise$15.8270,1801,110,248342,097Aug 14, 2018, 04:07 PM
ENDPPresident, CEOFeb 23, 2018 Option Exercise$6.789426,387269,777Feb 27, 2018, 12:00 AM
ENDPPresident, CEOFeb 21, 2018 Option Exercise$6.7224,184162,516267,763Feb 22, 2018, 06:43 PM
ENDPPresident, CEOSep 28, 2017 Option Exercise$8.381,33011,145216,132Oct 02, 2017, 04:50 PM
ENDPPresident, CEOAug 14, 2017 Buy$7.716,50050,115213,620Aug 15, 2017, 02:31 PM
ENDPPresident, CEOMar 16, 2017 Buy$10.722,30024,656207,120Mar 16, 2017, 05:54 PM
ENDPPresident, CEOFeb 23, 2017 Option Exercise$13.221,06614,093204,820Feb 27, 2017, 02:44 PM
ENDPPresident & CEOSep 28, 2016 Option Exercise$22.261,98144,097202,930Sep 28, 2016, 06:25 PM
ENDPGroup President, GenericsMay 10, 2016 Buy$15.5313,000201,890201,069May 11, 2016, 02:20 PM
ENDPPresident, Par PharmaceuticalNov 11, 2015 Buy$55.692,100116,954188,069Nov 12, 2015, 07:35 AM
PRXChief Executive OfficerSep 28, 2012 Option Exercise$50.0046,0172,300,8500Oct 02, 2012, 03:45 PM
PRXChief Operating OfficerJan 11, 2012 Option Exercise$35.651,10239,28646,106Jan 13, 2012, 04:54 PM
PRXChief Operating OfficerJan 06, 2012 Option Exercise$34.0180627,41247,118Jan 09, 2012, 06:20 PM
PRXChief Operating OfficerJan 04, 2012 Option Exercise$32.171,06234,16547,924Jan 06, 2012, 05:10 PM
PRXChief Operating OfficerNov 21, 2011 Option Exercise$29.567,009207,18649,794Nov 22, 2011, 05:18 PM
PRXEVP, Pres-Par PharmaceuticalMar 22, 2011 Option Exercise$29.003,03988,13156,803Mar 24, 2011, 05:23 PM
PRXEVP, Pres-Par PharmaceuticalMar 08, 2011 Sale$30.7347,7201,466,397107,080Mar 09, 2011, 06:55 PM
PRXEVP, Pres-Par PharmaceuticalMar 08, 2011 Sale$30.514,350132,738111,812Mar 09, 2011, 06:24 PM
PRXEVP, Pres-Par PharmaceuticalMar 07, 2011 Sale$31.0510,718332,805121,930Mar 09, 2011, 06:24 PM
PRXEVP, Pres-Par PharmaceuticalMar 07, 2011 Option Exercise$14.51116,3351,688,010228,277Mar 09, 2011, 05:57 PM
PRXEVP, Pres-Par PharmaceuticalMar 07, 2011 Sale$30.76105,6473,249,700227,531Mar 09, 2011, 05:57 PM
PRXEVP, Pres-Par PharmaceuticalJan 11, 2011 Option Exercise$35.9821,348768,101111,888Jan 13, 2011, 06:23 PM
PRXEVP, Pres-Par PharmaceuticalJan 04, 2011 Option Exercise$37.791,06240,133102,763Jan 06, 2011, 05:30 PM
PRXEVP, Pres-GenericsDec 20, 2006 Option Exercise$38.262,49695,497103,825Dec 22, 2010, 01:59 PM
PRXEVP, Pres-Par PharmaceuticalNov 18, 2001 Option Exercise$37.7214,019528,797106,321Nov 19, 2010, 05:13 PM

Desktop Version

SymbolRelationshipDateTransactionValue($)
ENDPDirectorApr 06, 2021 Option Exercise1,388,390
ENDPDirectorApr 02, 2021 Option Exercise1,078,968
ENDPDirectorMar 29, 2021 Option Exercise533,301
ENDPDirectorAug 10, 2020 Option Exercise397,083
ENDPDirectorApr 02, 2020 Option Exercise462,624
ENDPDirectorMar 29, 2020 Option Exercise256,700
ENDPPresident, CEOFeb 25, 2020 Option Exercise575,521
ENDPPresident, CEOFeb 23, 2020 Option Exercise6,178
ENDPPresident, CEOFeb 21, 2020 Option Exercise149,699
ENDPPresident, CEOSep 28, 2019 Option Exercise5,847
ENDPPresident, CEOAug 10, 2019 Option Exercise290,807
ENDPPresident, CEOApr 02, 2019 Option Exercise1,185,840
ENDPPresident, CEOFeb 23, 2019 Option Exercise10,489
ENDPPresident, CEOFeb 21, 2019 Option Exercise251,030
ENDPPresident, CEOSep 28, 2018 Option Exercise30,095
ENDPPresident, CEOAug 10, 2018 Option Exercise1,110,248
ENDPPresident, CEOFeb 23, 2018 Option Exercise6,387
ENDPPresident, CEOFeb 21, 2018 Option Exercise162,516
ENDPPresident, CEOSep 28, 2017 Option Exercise11,145
ENDPPresident, CEOAug 14, 2017 Buy50,115
ENDPPresident, CEOMar 16, 2017 Buy24,656
ENDPPresident, CEOFeb 23, 2017 Option Exercise14,093
ENDPPresident & CEOSep 28, 2016 Option Exercise44,097
ENDPGroup President, GenericsMay 10, 2016 Buy201,890
ENDPPresident, Par PharmaceuticalNov 11, 2015 Buy116,954
PRXChief Executive OfficerSep 28, 2012 Option Exercise2,300,850
PRXChief Operating OfficerJan 11, 2012 Option Exercise39,286
PRXChief Operating OfficerJan 06, 2012 Option Exercise27,412
PRXChief Operating OfficerJan 04, 2012 Option Exercise34,165
PRXChief Operating OfficerNov 21, 2011 Option Exercise207,186
PRXEVP, Pres-Par PharmaceuticalMar 22, 2011 Option Exercise88,131
PRXEVP, Pres-Par PharmaceuticalMar 08, 2011 Sale1,466,397
PRXEVP, Pres-Par PharmaceuticalMar 08, 2011 Sale132,738
PRXEVP, Pres-Par PharmaceuticalMar 07, 2011 Sale332,805
PRXEVP, Pres-Par PharmaceuticalMar 07, 2011 Option Exercise1,688,010
PRXEVP, Pres-Par PharmaceuticalMar 07, 2011 Sale3,249,700
PRXEVP, Pres-Par PharmaceuticalJan 11, 2011 Option Exercise768,101
PRXEVP, Pres-Par PharmaceuticalJan 04, 2011 Option Exercise40,133
PRXEVP, Pres-GenericsDec 20, 2006 Option Exercise95,497
PRXEVP, Pres-Par PharmaceuticalNov 18, 2001 Option Exercise528,797

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe